Efficacy and Safety Study of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy

Clinical trial NCT01067222 · COMPLETED

Trial details

NCT number: NCT01067222
Sponsor: Bioprojet
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Narcolepsy Excessive Daytime Sleepiness Cataplexy Sleep Disorders

Start date: 2009-05-01
Primary completion: 2010-07-01
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.